Patents by Inventor Han-Byoel LEE

Han-Byoel LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A Method for Predicting Prognosis of Cancer and the Composition Thereof
    Publication number: 20220267855
    Abstract: The present disclosure relates to a method for predicting prognosis of cancer and a composition thereof. More specifically, the present disclosure relates to a composition and a method for predicting prognosis of breast cancer and predicting the treatment effect of chemotherapy. The present disclosure provides gene expression information useful for predicting whether a cancer patient is more likely to respond favorably to treatment in chemotherapy.
    Type: Application
    Filed: April 28, 2020
    Publication date: August 25, 2022
    Inventors: Won Shik Han, Han Byoel Lee, In Ae Park, Han Suk Ryu, Sei Hyun Ahn, Jong Won Lee, Sae Byul Lee, Hee Jin Lee, Ae Ree Kim, Chung Yeul Kim, Sung Roh Yoon, Sun Kim, Sun Young Kwon, Min Su Kim, Jeong Hee Jo
  • Biomarker for measurement of response and prognosis of triple-negative breast cancer to anticancer agent
    Patent number: 11339446
    Abstract: The present disclosure discloses a biomarker capable of predicting the therapeutic response to anticancer agents and prognosis of triple-negative breast cancer patients, and the use thereof. A biomarker according to the present disclosure allows the provision of optimized personal therapeutic methods through correct personalized treatment, contributing to the quality and prolongation of life of patients.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: May 24, 2022
    Assignees: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, INDUSTRY-ACADEMIC COOPERATION FOUNDATION OF SUNCHON NATIONAL UNIVERSITY, SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Wonshik Han, Dong-Young Noh, Han-Byoel Lee, Eun-Kyu Kim, Ae-Kyung Park, Hyeong-Gon Moon
  • BIOMARKER FOR MEASUREMENT OF RESPONSE AND PROGNOSIS OF TRIPLE-NEGATIVE BREAST CANCER TO ANTICANCER AGENT
    Publication number: 20200087733
    Abstract: The present disclosure discloses a biomarker capable of predicting the therapeutic response to anticancer agents and prognosis of triple-negative breast cancer patients, and the use thereof. A biomarker according to the present disclosure allows the provision of optimized personal therapeutic methods through correct personalized treatment, contributing to the quality and prolongation of life of patients.
    Type: Application
    Filed: March 8, 2018
    Publication date: March 19, 2020
    Inventors: Wonshik HAN, Dong-Young NOH, Han-Byoel LEE, Eun-Kyu KIM, Ae-Kyung PARK, Hyeong-Gon MOON